China Healthwise Holdings Limited (HKG:0348)

Hong Kong · Delayed Price · Currency is HKD

0.0580

+0.0010 (1.75%)

Jul 31, 2026, 2:48 PM HKT

China Healthwise Holdings Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	99.56	99.56	113.58	146.32	142.06	170.08
Revenue Growth	-3.99%	-12.34%	-22.38%	3.00%	-16.48%	23.38%
Gross Profit	36.62	36.62	35	-47.18	28.49	-11.61
Operating Income	-12.63	-12.63	-20.45	-112.58	-38.39	-75.79
Net Income	-2.61	-2.61	-40.28	-134.56	-54.27	-103.05
Earnings Per Share	-0.00	-0.00	-0.05	-0.17	-0.07	-0.13
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Chinese Health Products	99.2	99.2	112.83	129.52	128.38	114.2
Investment in Financial Instruments	-0.25	-0.25	-0.39	6.14	-0.95	33.59
Money Lending Business	0.61	0.61	1.13	10.66	14.63	22.29
Total	99.56	99.56	113.58	146.32	142.06	170.08

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	66.16	66.16	48.15	59.16	78.73	101.62
Total Debt	106.13	106.13	103.74	108.9	109.9	90.86
Net Cash (Debt)	-39.98	-39.98	-55.59	-49.74	-31.17	10.76
Net Cash Growth	-	-	-	-	-	-65.68%
Net Cash Per Share	-0.05	-0.05	-0.07	-0.06	-0.04	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	15.05	15.05	3.13	14.49	-28.34	42.08
Capital Expenditures	-0.09	-0.09	-0.26	-0.19	-0.63	-0.36
Free Cash Flow	14.96	14.96	2.87	14.3	-28.97	41.72
Free Cash Flow Growth	177.61%	420.36%	-79.90%	-	-	458.39%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	36.78%	36.78%	30.82%	-32.24%	20.05%	-6.83%
Operating Margin	-12.68%	-12.68%	-18.01%	-76.94%	-27.02%	-44.56%
Pretax Margin	-3.31%	-3.31%	-35.24%	-90.26%	-39.70%	-59.14%
Profit Margin	-2.62%	-2.62%	-35.47%	-91.96%	-38.21%	-60.59%
FCF Margin	15.02%	15.02%	2.53%	9.77%	-20.39%	24.53%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	3.04	7.01	41.55	2.21	-	5.17
PS Ratio	0.46	1.05	1.05	0.22	1.02	1.27